This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human IFN-alpha 2 (alpha 2b) Protein
catalog :
11105-1
quantity :
100000 UN
price :
374 USD
citations: 8
Reference
Scott H, Draganov S, Yu Z, Kessler B, Pinto Fern xe1 ndez A. Targeted Mass Spectrometry Reveals Interferon-Dependent Eicosanoid and Fatty Acid Alterations in Chronic Myeloid Leukaemia. Int J Mol Sci. 2023;24: pubmed publisher
Pietraforte I, Butera A, Gaddini L, Mennella A, Palazzo R, Campanile D, et al. CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells. Int J Mol Sci. 2022;24: pubmed publisher
Wilkinson C, Kyle J, Irimpen M, Stuart S, Mohandass S, Sheperd A, et al. Improved yield of recombinant human IFN-α2b from mammalian cells using heterologous signal peptide approach. Protein Expr Purif. 2022;198:106125 pubmed publisher
Kell A, Hemann E, Turnbull J, Gale M. RIG-I-like receptor activation drives type I IFN and antiviral signaling to limit Hantaan orthohantavirus replication. PLoS Pathog. 2020;16:e1008483 pubmed publisher
He C, Lv X, Huang C, Angeletti P, Hua G, Dong J, et al. A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis. Cell Rep. 2019;26:2636-2650.e5 pubmed publisher
Abdel Mohsen M, Deng X, Danesh A, Liegler T, Jacobs E, Rauch A, et al. Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo. PLoS ONE. 2014;9:e109220 pubmed publisher
Wilson T, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature. 2012;487:505-9 pubmed publisher
Lee P, Li Y, Richards H, Chan F, Zhuang H, Narain S, et al. Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum. 2007;56:3759-69 pubmed
product information
master code :
11105-1
SKU :
11105-1
product name :
Recombinant Human IFN-alpha 2 (alpha 2b) Protein
unit size :
100000 UN
description :
The Recombinant Human IFN-alpha 2 (alpha 2b) Protein from R&D Systems is derived from E. coli.
target :
IFN-alpha 2/IFNA2
category :
Proteins and Enzymes
conjugate :
Unconjugated
species :
Human
gene symbol :
IFNA2
source short :
E. coli
USD :
374 USD
alt names :
alpha-2a interferon, Ifa2, IFNA, IFNA2, IFNA2a, IFNA2b, IFNA2c, IFNAA, IFNalpha 2, IFN-alpha-2, IFN-alphaA, INFA2, interferon alpha 2b, interferon alpha A, interferon alpha-2, Interferon alpha-A, interferon, alpha 2, LeIF A, MGC125764, MGC125765
storage :
Store the unopened product at -20 to -70 ░C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.